Hüppa põhisisu juurde
Raamatukoi
Tõde ja õigus

The LDN Book 3

Low Dose Naltrexone

Linda Elsegood (toim.) · LDN Research Trust · 2022

The LDN Book 3

Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers. It has been used to help those with autism, chronic fatigue, and depression find relief, and latest research points to its potential for long covid, mold toxicity, even longevity. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? Find out more about the potential of LDN from leading international medical professionals in this updated, third book, edited by Linda Elsegood, founder of The LDN Trust.

Saadavus
31,50 €

Uus kasutamata raamat

Täna tellides on tarneaeg umbes 9 päeva (27.11.2026)Tellimuse täitmise aeg on umbkaudne ja sõltub nädalapäevast, millal tellimus tehakse. Reeglina ei kulu üle kahe nädala.

Tarne ja kättesaamine

Detailid

Alapealkiri
Low Dose Naltrexone
Autor
Linda Elsegood (toim.)
ISBN
9781739107000
Aasta
2022
Keel
inglise
Köide
Pehme kaas
Lehekülgi
316
Teema
Tervis ja eneseareng › Pere ja tervis — Family & health
Kaal
674 g